NCT00242788View on ClinicalTrials.gov

IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

November 30, 2005

Conditions
Colorectal Cancer
Interventions
DRUG

Gefitinib and capecitabine

Trial Locations (6)

Unknown

Research Site, Girona

Research Site, Leganés

Research Site, Madrid

Research Site, Málaga

Research Site, Santander

Research Site, Zaragoza

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY